Literature DB >> 11112352

Cloning and characterization of human NTT5 and v7-3: two orphan transporters of the Na+/Cl- -dependent neurotransmitter transporter gene family.

M K Farmer1, M J Robbins, A D Medhurst, D A Campbell, K Ellington, M Duckworth, A M Brown, D N Middlemiss, G W Price, M N Pangalos.   

Abstract

Orphan transporters form a growing subfamily of genes related by sequence similarity to the Na+/Cl- -dependent neurotransmitter superfamily. Using a combination of database similarity searching and cloning methods, we have identified and characterized two novel human orphan transporter genes, v7-3 and NTT5. Similar to other known orphan transporters, v7-3 and NTT5 contain 12 predicted transmembrane domains, intracellular N- and C-terminal domains, and large extracellular loops between transmembrane (TM) domains 3 and 4 and between TM domains 7 and 8. Residues within the extracellular loops are also predicted to contain sites for N-linked glycosylation. Human v7-3, the species orthologue of rat v7-3, contains an open reading frame (ORF) of 730 amino acids. Human NTT5 is a new member of the orphan transporter family and has an ORF of 736 amino acids. The amino acid sequences of human v7-3 and NTT5 are greater than 50% similar to other known orphan neurotransmitter transporters and also show sequence similarity to the human serotonin and dopamine transporters. Radiation hybrid mapping located the human v7-3 and NTT5 genes on chromosomes 12q21.3-q21.4 and 19q13.1-q13.4, respectively. Human mRNA distribution analysis by TaqMan reverse transcription-polymerase chain reaction showed that v7-3 mRNA is predominantly expressed in neuronal tissues, particularly amygdala, putamen, and corpus callosum, with low-level expression in peripheral tissues. In contrast, NTT5 mRNA was highly expressed in peripheral tissues, particularly in testis, pancreas, and prostate. Transient transfection with epitope-tagged transporter constructs demonstrated v7-3 to be expressed at the cell surface, whereas NTT5 was predominantly intracellular, suggestive of a vesicular location. Although the substrates transported by these transporters remain unknown, their specific but widespread distribution suggests that they may mediate distinct and important functions within the brain and the periphery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112352     DOI: 10.1006/geno.2000.6387

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

Review 1.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

Review 2.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  SNF-10 connects male-derived signals to the onset of sperm motility in C. elegans.

Authors:  Kristin E Fenker; Gillian M Stanfield
Journal:  Worm       Date:  2015-01-29

4.  The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2).

Authors:  Angelika Bröer; Nadine Tietze; Sonja Kowalczuk; Sarah Chubb; Michael Munzinger; Lasse K Bak; Stefan Bröer
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

5.  SLC6 family transporter SNF-10 is required for protease-mediated activation of sperm motility in C. elegans.

Authors:  Kristin E Fenker; Angela A Hansen; Conrad A Chong; Molly C Jud; Brittany A Duffy; J Paul Norton; Jody M Hansen; Gillian M Stanfield
Journal:  Dev Biol       Date:  2014-06-12       Impact factor: 3.582

6.  Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport.

Authors:  Kimberly A Zaia; Richard J Reimer
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

7.  Hypertension and impaired glycine handling in mice lacking the orphan transporter XT2.

Authors:  Hui Quan; Krairerk Athirakul; William C Wetsel; Gonzalo E Torres; Robert Stevens; Y T Chen; Thomas M Coffman; Marc G Caron
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviors.

Authors:  Jana Drgonova; Qing-Rong Liu; F Scott Hall; Rachael M Krieger; George R Uhl
Journal:  Brain Res       Date:  2007-09-14       Impact factor: 3.252

9.  The neuronal transporter gene SLC6A15 confers risk to major depression.

Authors:  Martin A Kohli; Susanne Lucae; Philipp G Saemann; Mathias V Schmidt; Ayse Demirkan; Karin Hek; Darina Czamara; Michael Alexander; Daria Salyakina; Stephan Ripke; David Hoehn; Michael Specht; Andreas Menke; Johannes Hennings; Angela Heck; Christiane Wolf; Marcus Ising; Stefan Schreiber; Michael Czisch; Marianne B Müller; Manfred Uhr; Thomas Bettecken; Albert Becker; Johannes Schramm; Marcella Rietschel; Wolfgang Maier; Bekh Bradley; Kerry J Ressler; Markus M Nöthen; Sven Cichon; Ian W Craig; Gerome Breen; Cathryn M Lewis; Albert Hofman; Henning Tiemeier; Cornelia M van Duijn; Florian Holsboer; Bertram Müller-Myhsok; Elisabeth B Binder
Journal:  Neuron       Date:  2011-04-28       Impact factor: 17.173

Review 10.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.